Fierce Pharma publisher Rebecca Willumson caught up with ixlayer’s General Manager of Biopharma, Matthew Walsh, at Digital Pharma East 2025 for a quick interview about the current and future state of pharma marketing.
Moving Pharmacy Upstream: The Strength of Earlier Pharmacy Integration For pharmaceutical marketers, campaign performance often
New Performance Data Shows Why Pharma Is Reallocating Spend Toward Direct-to-Patient Care Pharmaceutical brands are
Fierce Pharma highlights pharma’s shift toward direct-to-patient models A recent Fierce Pharma article examines how
MediaPost Highlights Need to Move From Awareness to Action “Pharma Ads Losing Effectiveness? Try Direct-To-Patient
Moving Pharmacy Upstream: The Strength of Earlier Pharmacy Integration For pharmaceutical marketers, campaign performance often boils down to one metric:
New Performance Data Shows Why Pharma Is Reallocating Spend Toward Direct-to-Patient Care Pharmaceutical brands are increasingly shifting investment toward direct-to-patient
Fierce Pharma highlights pharma’s shift toward direct-to-patient models A recent Fierce Pharma article examines how pharmaceutical companies are increasingly experimenting
